ML830 Cold Laser Therapy by Microlight ( FDA Approved ) - gently used, US $2,500.00 – Picture 0

ML830 Cold Laser Therapy by Microlight ( FDA Approved ) - gently used, US $2,500.00 – Picture 1

Ml830 Cold Laser Therapy By Microlight ( Fda Approved ) - Gently Used

US $2,500.00

Oviedo, Florida, United States
Jan 30th

Open on mobile:
QR code

ML830 Cold Laser by Microlight 1. The Microlight 830 Laser is indicated for adjunctive use in the temporary relief of hand and wrist pain associated with Carpal Tunnel Syndrome. 2. Temporary relief of minor muscle and joint pain, arthritis and muscle spasm; temporary relief of stiffness and promotion of muscle tissue relaxation; and temporary increase of local blood circulation. SPECS Diodes Three gallium aluminum arsenide laser diodes Coherent Beam travels in a straight line Monochromatic Form a single wavelength Polarized Beam is concentrated in one location or spot Power 30 milli watts per diode Wavelength 830 nanometers Energy Delivers 3 joules of energy per 33 second treatment cycle WHAT IT IS The Microlight ML830® is a non-invasive, light-emitting, medical device. Approved by the FDA for sale and use in the treatment of a variety of soft and connective tissue disorders as well as certain neurological disorders, this device is a low energy laser also known as a “cold laser.” In contrast to general surgical or cosmetic lasers that produce heat and thermo-destructive laser energy, Low Level Laser Therapy (LLLT) produces no harm to human tissue in normal use and thus is classified by the FDA as a Class III B medical device. Cold lasers used in LLLT have been in medical use for over 30 years and have a long record of successful clinical studies demonstrating medical efficacy and safety. The Microlight ML830® produces infrared (invisible) laser light at the 830 nm wavelength via three LASER diodes. A fourth visible LED (Light-Emitting Diode) is used to provide a visible red target light field for the clinician to target the desired tissue area. As a noninvasive contact medical device, the Microlight ML830® is completely portable, very easy to operate and provides reliable and effective treatment options to the clinician and patient. WHAT IT DOES Studies have shown that through the action of photo-stimulation of light reactive biological receptors (chromophores) in the body, Low Level Laser Therapy (LLLT) has demonstrated the ability to significantly accelerate and enhance the body’s natural defense and repair components in the presence of injury, inflammation and certain disease processes. Studies have also shown that by modifying the effects and limiting the duration of inflammation as well as enhancing specific repair and healing processes, LLLT is consistent in providing pain relief, reducing injury damage and loss of function, in addition to facilitating more rapid repair and stronger healed tissue structures. Multiple clinical studies have noted the following results of LLLT: • Increased collagen production • Enhanced nerve regeneration • Increased vasodilation • Reduced inflammatory duration • Increased cell metabolism • Increased pain threshold • Increased cell membrane potential • Reduced edema magnitude • Increased microcirculation • Increased tissue and bone repair • Increased lymphatic response • Increased enzyme response HOW IT WORKS Studies show that as light receptive chromophores in various tissues, in both cellular and sub-cellular locations, are irradiated with coherent laser light, energy transfers occur that stimulates more active levels of function and increased interaction. Laser light, penetrating much deeper than other light wave forms, activates increased mitochondrial ATP synthesis, produces increased mast cell inflammatory mitigation and stimulates increased Ca2+ ion presence and beneficial reactive oxygen species (ROS) production. Through the action of photo bio-stimulation, oxidative metabolism is increased via cytochrome C oxidase and photosensitization of hemoglobin. Laser irradiation stimulates increased endorphin release and increased prostaglandin synthesis. Due to the powerful effect photo-stimulated enzymes exert, both localized and systemic cascade reactions occur that result in immunomodulation and inflammatory mitigation. Damaged skeletal, connective and neurological tissues and structures react with enhanced healing in the presence of low level laser irradiation as collagen synthesis and production, satellite cell presence and cellular metabolism are increased as a result of the light stimulation and improved vascular, lymphatic and enzymatic activity. PENETRATION The ML830 is a GaAlA Laser that has wavelength of 830 nm with a power output of 90 mw. At this wavelength and power the ML830 Laser has a penetration of approximately 5 cm with a 3 cm lateral spread. It is not an accident that the Microlight Corporation of America chose & patented the 830nm technology for its ML830®. There are 30+ years of clinical studies that proved the 830nm range is the optimal wave-length.